Cardio IQ® Lipoprotein Fractionation, Ion Mobility Blood Test
The Cardio IQ® Lipoprotein Fractionation, Ion Mobility Blood Test measures the different types of lipoproteins in the blood and assesses the risk of developing cardiovascular disease.
Methodology:
Ion Mobility
Preparation:
Fasting is not required but is preferred.
Test Results:
3-7 days. May take longer based on weather, holiday, or lab delays.
Walk-In Lab is prohibited from selling Quest tests to residents in the following states:AZ, NY, NJ, RI
What is the purpose of this test?
The Cardio IQ® Lipoprotein Fractionation, Ion Mobility Blood Test offered by Quest Diagnostics is a blood test that helps assess an individual's risk for heart disease. It measures the number and size of different types of lipoprotein particles in the blood, which are responsible for transporting cholesterol and triglycerides throughout the body. The test uses advanced technology called ion mobility, which allows for improved accuracy and precision in measuring lipoprotein particles.
Compared to traditional cholesterol tests, which only measure total cholesterol levels and provide limited information about an individual's risk for heart disease, the Cardio IQ® test provides a more comprehensive assessment. It measures specific types of lipoprotein particles, such as LDL (low-density lipoprotein) and HDL (high-density lipoprotein), which are known to play a key role in the development of heart disease.
Overall, the Cardio IQ® Lipoprotein Fractionation, Ion Mobility Blood Test is a valuable tool for assessing an individual's risk for heart disease and guiding appropriate treatment options.
The Cardio IQ® Lipoprotein Fractionation, Ion Mobility Blood Test includes the following:
- LDL Particle Number - LDL particle number refers to the number of low-density lipoprotein particles present in the blood.
- LDL Small - LDL small refers to the type of low-density lipoprotein cholesterol particles that are smaller and denser than normal, which can increase the risk of heart disease.
- LDL Medium - LDL medium refers to the type of low-density lipoprotein cholesterol particles that are intermediate in size between small and large, which may or may not increase the risk of heart disease.
- HDL Large - An HDL large refers to the larger type of high-density lipoprotein cholesterol particles that are known to have a protective effect against heart disease.
- LDL Pattern - An HDL large refers to the larger type of high-density lipoprotein cholesterol particles that are known to have a protective effect against heart disease.
- LDL Peak Size - LDL peak size refers to the size of the particles that carry cholesterol in the blood, and larger particles are considered to be less harmful than smaller particles.
Benefits of the Cardio IQ® Lipoprotein Fractionation, Ion Mobility Blood Test:
- Comprehensive analysis: Provides detailed information on lipoprotein subclasses, including LDL and HDL, allowing for a more comprehensive assessment of cardiovascular risk.
- Advanced technology: Utilizes advanced ion mobility technology to separate lipoprotein particles based on size, providing greater accuracy and sensitivity in detecting lipid abnormalities.
- Precise risk assessment: Offers a more accurate evaluation of cardiovascular risk compared to traditional lipid panels by identifying specific lipid particles associated with increased risk, such as small, dense LDL particles.
- Personalized treatment guidance: Helps healthcare providers tailor treatment plans based on individual lipid profiles, allowing for more targeted interventions to reduce cardiovascular risk.
- Early detection of cardiovascular disease: Identifies lipid abnormalities at an early stage, enabling proactive management and intervention to prevent the progression of cardiovascular disease.
- Improved patient outcomes: By providing a more comprehensive assessment of cardiovascular risk factors, the test may contribute to improved patient outcomes through early detection and targeted treatment strategies.
- Enhanced monitoring of treatment efficacy: Allows for ongoing monitoring of lipid levels and particle size distribution, enabling healthcare providers to assess the effectiveness of interventions and adjust treatment plans as needed.
- Patient education: Provides patients with valuable insights into their lipid profile and cardiovascular risk factors, empowering them to take proactive steps towards improving their heart health through lifestyle modifications and medication adherence.
